This study investigates the distribution of a substance called 68Ga-P16-093 in the bodies of prostate cancer patients who have experienced a return of cancer, known as biochemical recurrence. The purpose of this study is to understand how this substance spreads through the body and how much radiation patients are exposed to during this process. Researchers will use a special type of scan called PET to measure how much of the substance different organs absorb over time.
Participants will undergo PET scans to track the movement of 68Ga-P16-093 in their bodies. The study will also compare the effectiveness of this substance to another one, 68Ga-PSMA-11, in finding areas where the cancer might have returned. The PET scan is a procedure where a machine takes pictures of the inside of the body after a special substance is injected. This helps doctors see where the cancer might be.
- Who can participate: Men with prostate cancer and rising PSA levels post-surgery are eligible. They must have confirmed prostate cancer and be scheduled for another surgery soon.
- Study details: Participants will receive an injection of the investigational substance and then undergo PET scans. The scans will help determine how the substance moves through the body and how it compares to another similar substance in detecting cancer.
